• 1. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 2. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 3. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 4. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 5. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridopyrimidines Pyrido[2,3-d]pyrimidines

Introduction to 6-Bromopyrido[2,3-d]pyrimidin-2-amine (CAS No. 882670-89-5) and Its Emerging Applications in Chemical Biology and Medicinal Chemistry

6-Bromopyrido[2,3-d]pyrimidin-2-amine, identified by the chemical identifier CAS No. 882670-89-5, is a heterocyclic compound that has garnered significant attention in the fields of chemical biology and medicinal chemistry due to its versatile structural framework and potential biological activities. This bicyclic amine derivative belongs to the pyrido[2,3-d]pyrimidine class, a scaffold that has been extensively explored for its pharmacological relevance. The presence of a bromine substituent at the 6-position and an amine group at the 2-position enhances its reactivity, making it a valuable intermediate in synthetic chemistry and drug discovery programs.

The pyrido[2,3-d]pyrimidine core is a privileged structure in medicinal chemistry, known for its ability to interact with various biological targets, including enzymes and receptors. This class of compounds has been implicated in diverse therapeutic areas, such as anticancer, antiviral, and anti-inflammatory treatments. The introduction of functional groups like bromine and amine further expands its utility by enabling further derivatization through cross-coupling reactions, nucleophilic substitutions, and other synthetic transformations.

Recent advancements in the field have highlighted the significance of 6-Bromopyrido[2,3-d]pyrimidin-2-amine in the development of novel therapeutic agents. For instance, studies have demonstrated its potential as a precursor in the synthesis of kinase inhibitors, which are critical in targeted cancer therapies. Kinases play a pivotal role in cell signaling pathways, and their dysregulation is often associated with diseases such as cancer. By modifying the pyrido[2,3-d]pyrimidine scaffold, researchers have been able to design molecules that selectively inhibit aberrant kinase activity.

The bromine substituent at the 6-position of 6-Bromopyrido[2,3-d]pyrimidin-2-amine is particularly noteworthy, as it serves as an excellent handle for palladium-catalyzed cross-coupling reactions. These reactions are fundamental in constructing complex molecular architectures and have been widely employed in drug development. For example, Suzuki-Miyaura coupling allows for the introduction of aryl or heteroaryl groups, while Buchwald-Hartwig amination facilitates the connection of amino groups. Such transformations have enabled the synthesis of structurally diverse analogs with enhanced biological properties.

In addition to its role in kinase inhibition, preliminary studies have explored the potential of 6-Bromopyrido[2,3-d]pyrimidin-2-amine in other therapeutic contexts. Its structural motif has been found to mimic natural products that exhibit antimicrobial activities. The amine group at the 2-position can be further functionalized to introduce pharmacophores that interact with bacterial enzymes or interfere with essential metabolic pathways. This opens up avenues for developing novel antibiotics or antifungal agents against resistant strains.

The synthesis of 6-Bromopyrido[2,3-d]pyrimidin-2-amine itself is an intriguing challenge due to its complex heterocyclic system. However, modern synthetic methodologies have made significant strides in facilitating access to this scaffold. Catalytic hydrogenation techniques can be employed to reduce double bonds within the pyridopyrimidine ring, while nucleophilic aromatic substitution can be used to introduce the bromine atom at the desired position. These advances have not only improved yield but also reduced reaction times, making large-scale production more feasible.

The growing interest in 6-Bromopyrido[2,3-d]pyrimidin-2-amine has also spurred research into its computational modeling and virtual screening applications. Molecular docking studies have been conducted to predict its binding affinity to various biological targets. These computational approaches complement experimental efforts by providing rapid screening of potential drug candidates before they are synthesized and tested in vitro or in vivo. Such integrative strategies are becoming increasingly important in modern drug discovery pipelines.

Future directions in the study of 6-Bromopyrido[2,3-d]pyrimidin-2-amine include exploring its role in modulating immune responses and inflammatory processes. The pyrido[2,3-d]pyrimidine scaffold has shown promise in inhibiting Janus kinases (JAKs), which are central mediators of cytokine signaling. By designing derivatives of 6-Bromopyrido[2,3-d]pyrimidin-2-amine, researchers aim to develop immunomodulatory agents that could be used to treat autoimmune diseases or enhance vaccine efficacy.

The versatility of CAS No. 882670-89-5, particularly its reactivity facilitated by the bromine and amine functional groups, makes it a valuable building block for medicinal chemists. Its ability to undergo diverse transformations while maintaining structural integrity ensures that it remains a cornerstone in synthetic efforts aimed at discovering novel therapeutics. As research continues to uncover new biological functions and synthetic methodologies for this compound class, applications are expected to expand into yet unexplored therapeutic domains.

• 152941-69-0(6-Bromopyrido[2,3-d]pyrimidine-2,4-diamine)
• 17965-79-6(1,8-Naphthyridine, 3,6-dibromo-)
• 1556457-89-6(5-Bromo-7H-pyrrolo[2,3-d]pyrimidin-2-amine)
• 1121633-45-1(6-Bromopyrido[2,3-d]pyrimidin-4-amine)
• 17965-78-5(3-bromo-1,8-naphthyridine)
• 882670-90-8(6-Bromo-N-methylpyrido[2,3-d]pyrimidin-2-amine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)